Autoreactive B cells in SLE, villains or innocent bystanders?

IMMUNOLOGICAL REVIEWS(2019)

Cited 46|Views24
No score
Abstract
The current concepts for development of autoreactive B cells in SLE (systemic lupus erythematosus) focus on extrinsic stimuli and factors that provoke B cells into tolerance loss. Traditionally, major tolerance loss pathways are thought to be regulated by factors outside the B cell including autoantigen engagement of the B-cell receptor (BCR) with simultaneous type I interferon (IFN) produced by dendritic cells, especially plasmacytoid dendritic cells (pDCs). Later, in autoreactive follicles, B-cells encounter T-follicular helper cells (Tfh) that produce interleukin (IL)-21, IL-4 and pathogenic cytokines, IL-17 and IFN gamma (IFN gamma). This review discusses these mechanisms and also highlights recent advances pointing to the peripheral transitional B-cell stage as a major juncture where transient autocrine IFN beta expression by developing B-cells imprints a heightened susceptibility to external factors favoring differentiation into autoantibody-producing plasmablasts. Recent studies highlight transitional B-cell heterogeneity as a determinant of intrinsic resistance or susceptibility to tolerance loss through the shaping of B-cell responsiveness to cytokines and other environment factors.
More
Translated text
Key words
autoantibodies,autoimmunity,BXD2,follicular T-helper cells,germinal center B cells,IFN beta,IL-17,IL-21,lupus,lymphotoxin beta,marginal zone macrophages,marginal zone-precursor B cells,plasmacytoid dendritic cells,regulator of G-protein signaling,SLE,transitional stage 1 B cells,type I IFNs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined